Overcoming Drug Resistance Patterns in Non-Responders: Proven Best Practices on Informing Your Clinical Strategy, New Webinar Hosted by Xtalks
TORONTO (PRWEB) March 07, 2019 -- Many standard of care (SOC) treatments in cancer patients result in a clinical outcome of non-response. Drug development companies are trending toward interrogating resistance mechanisms and using this information in advancing their programs and informing personalized approaches to novel therapeutics.
Join Dr. Mark Paris, Director of Translational Applications at Mitra Biotech in a live session on Friday, March 22, 2019 at 12pm EDT (4pm GMT) to learn about:
• Key ingredients to testing hypotheses of specific resistance mechanisms that are involved in non-responders in a specific case study
• How various drug combinations may overcome these identified resistance mechanisms
• Discussion on how to improve clinical trial design
This webinar will benefit executives in small to mid-size biotech and pharmaceutical companies interested in learning more about how to save time and money while maximizing the value of their drug development clinical trial programs.
For more information or to register for this event, visit Overcoming Drug Resistance Patterns in Non-Responders: Proven Best Practices on Informing Your Clinical Strategy.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Candice Tang, Xtalks, http://www.xtalks.com, 4169776555, [email protected]
Share this article